Causal Therapy of COVID-19: Critical Review and Prospects
The COVID-19 outbreak started in December 2019 in China has spread over all countries of the world within few month acquiring a pandemic nature, the incident population counting millions. The pathogenic mechanisms of the new coronaviral infection caused by never-before-seen virus SARS-CoV2 are yet t...
Saved in:
| Main Authors: | N. V. Beloborodova, E. V. Zuev, M. N. Zamyatin, V. G. Gusarov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
2020-12-01
|
| Series: | Общая реаниматология |
| Subjects: | |
| Online Access: | https://www.reanimatology.com/rmt/article/view/1987 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19 Therapy: the Role of Antirheumatic Drugs
by: M. A. Litvinova, et al.
Published: (2021-10-01) -
Therapeutic potential of interleukin 6 inhibitors in difficult-to-treat patients with rheumatoid arthritis (results of a retrospective study)
by: I. V. Pozharov, et al.
Published: (2025-07-01) -
Canadian Consensus Guidelines for the Management of Atopic Dermatitis with Topical Therapies
by: Melinda J. Gooderham, et al.
Published: (2025-04-01) -
Canadian Consensus Guidelines for the Management of Vitiligo
by: Vimal H. Prajapati, et al.
Published: (2025-04-01) -
Janus kinase inhibitors in the treatment of psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2022-02-01)